IVZ vs HST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

IVZ

69.6
AI Score
VS
IVZ Wins

HST

34.9
AI Score

Investment Advisor Scores

IVZ

70score
Recommendation
HOLD

HST

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IVZ HST Winner
Forward P/E 9.5147 22.1729 IVZ
PEG Ratio 0.9008 3.3561 IVZ
Revenue Growth 20.5% 3.6% IVZ
Earnings Growth 35.0% 8.4% IVZ
Tradestie Score 69.6/100 34.9/100 IVZ
Profit Margin -0.9% 16.5% HST
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY IVZ

Relative Price Performance (Last 90 Days)

IVZ 1M: -6.7% · 3M: -4.2% HST 1M: +12.2% · 3M: +1.5%

Current Technical Phase

IVZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 40

RSI (14): 40.1 · Price: $28.68

HST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 74

RSI (14): 73.8 · Price: $24.86

Fundamentals Snapshot

Metric IVZ HST
Market Cap — —
Forward P/E 9.0 24.0
Trailing P/E — 16.8
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.2% 0.2%
EPS -0.68 1.48
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.